Allergan to Cut 1,500 Jobs; Saves $475M

Jul 22, 2014

Wall Street Journal

Wall Street Journal reported that it expected Allergan to cut costs as one way to fend off the unwanted $53 billion takeover bid from Valeant Pharmaceuticals and investor William Ackman.

Allergan reportedly is cutting 13% of its workforce, or about 1,500 jobs, and it will also leave 250 unfilled jobs vacant in order to save $475 million. The cuts do not include R&D programs and nearly all – 94%, specifically – of employees who deal directly with customers, such as doctors and hospitals, will remain in place. Read the full WSJ article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments